. This discovery, fuelled by the finding that the gene TET2 is frequently mutated in human blood cancers 3 , sparked intense interest in understanding the function and regulation of this enzyme family. Thienpont et al. 4 report on page 63 that TET activity is limited by oxygen supply -revealing a general mechanism by which gene expression can be silenced in solid tumours.
TET proteins belong to a dioxygenase enzyme family, members of which depend on three cofactors for their activity: divalent iron (Fe 2+ ), the metabolite α-ketoglutarate (αKG) and oxygen 5 . Fe 2+ in the active site of the enzyme is coordinated by αKG to split an oxygen molecule into two oxygen atoms. One oxygen atom attacks and breaks a carbon-carbon bond in αKG, leading to the conversion of the metabolite to succinate and the release of carbon dioxide. The other atom oxidizes a carbon-hydrogen bond in the enzyme's substrate (Fig. 1) . In TET-mediated reactions, methylated cytosine (5-methylcytosine, 5mC) is oxidized to 5-hydroxymethylcytosine (5hmC), and further oxidization follows, eventually leading to the removal of methyl groups and so to gene expression 6, 7 . In addition to mutations that inactivate TET genes, TET enzymes can be inactivated in tumours if their cofactors are unavailable. For example, the accumulation of αKG competitors such as the metabolites 2-hydroxyglutarate (2-HG) 8, 9 , succinate and fumarate 10 causes decreased TET activity. The discovery 11, 12 that these three metabolites accumulate in some tumours has led to the idea that cancerpromoting metabolites could have a general role in contributing to tumour development by altering the DNA-methylation landscape in cells, in much the same way that DNA damage causes cancer by altering the genomic landscape. Only a few types of cancer involve mutations in TET genes or show accumulation of αKG-competing metabolites. But the activity of TET enzymes -measured by the production of 5hmC -seems to be substantially decreased in a wide range of tumours 13 . This discrepancy has remained unexplained until now.
Solid tumours are oxygenated through blood vessels, but a tumour can rapidly outgrow its blood supply, leaving oxygen concentrations low in some regions. Thienpont et The authors considered 45 grassland sites across 6 continents, and measured species diversity in response to various nutrient additions. Their results provide strong evidence for a broad ecological theory -that the availability of multiple limiting resources allows plants with different limiting requirements to coexist.
The greater the number of limiting resources that were added, the more species were lost, although productivity and turnover improved. Figure 1 | Reducing TET activity through hypoxia. The addition of a methyl group (CH 3 ) to the DNA base cytosine to form 5-methylcytosine (5mC) can lead to silencing of many genes, including those that suppress tumour development. TET enzymes, acting with the cofactor molecules α-ketoglutarate (αKG) and oxygen, can trigger the demethylation of 5mC. In the first step of this reaction, O 2 is split into two atoms. One atom breaks a carbon-carbon bond in αKG, leading to succinate production and carbon dioxide release. The other oxidizes a carbon-hydrogen bond in CH 3 to form CH 2 OH, converting 5mC to 5-hydroxymethylcytosine (5hmC), eventually leading to gene expression. Thienpont et al. 4 report that a shortage of O 2 in solid tumours inhibits TET activity, leading to DNA hypermethylation.
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Muddy messages about American migration
When and by which paths did early humans migrate into America? An analysis of ancient plant and animal remains revises the timeframe during which a route may have opened between ice sheets in northwest America. See Article p.45 could explain the cases in which no decrease was seen.
Why do 5hmC levels decrease in most cancer-cell types in hypoxic conditions? Damaging molecules called reactive oxygen species, which could impair TET activity by reducing the amount of Fe 2+ , and metabolites that inhibit αKG such as 2-HG are known 14, 15 to be increased by hypoxia. High levels of these molecules could therefore impair TET activity. However, the authors excluded both as the cause of TET inhibition -supplements of vitamin C, which counteracts reactive oxygen species, or of αKG could not prevent 5hmC loss. Instead, analysis of enzyme kinetics predicted a 45% decrease of TET1 activity and a 52% decrease of TET2 activity in typical hypoxic tumour cells in mice. This is the first evidence that oxygen molecules are a ratelimiting factor for TET2 activity in tumours.
Cytosine methylation typically occurs at CpG dinucleotide sites, where cytosine and guanine bases are found side by side. The authors analysed CpG methylation in a few tumours. CpG sites in most genes displayed increased 5mC levels that were concomitant with reduced 5hmC levels following hypoxia, suggesting a causal link between hypoxia and DNA hypermethylation.
To test this link further, Thienpont et al. turned to previously established geneexpression patterns known to be a signature of hypoxia 16 , to assign tumours to hypoxic, normal or intermediate groups. The authors separately clustered the tumours into those that showed low, intermediate and high CpG methylation states. Hypoxic tumours predominated in the hypermethylated cluster, whereas normoxic tumours were enriched in the low-methylation cluster, providing further evidence that hypoxia leads to increased CpG methylation in tumours.
Thienpont and colleagues next found that hypoxia-linked 5hmC loss and concurrent 5mC gain were most apparent in promoter regions that drive gene expression -including the promoters of genes involved in DNA repair, the cell cycle, blood-vessel formation and cancer spread. Finally, the authors induced global loss of 5hmC in vivo by inducing hypoxia, and reversed this effect by deleting one copy of the oxygen-sensor gene Phd2, reduced function of which is known to restore tumour oxygenation 17 . Collectively, these results suggest that hypoxia causes TET inhibition, a reduction in 5hmC levels and DNA hypermethylation, leading to altered gene expression.
Oxygen shortage is unlikely to be the only factor that contributes to the widespread loss of 5hmC in tumours. 5hmC is a dynamic and transient modification that could be affected by changes in TET gene transcription, by posttranslational modifications of TET proteins or even by the dynamics of DNA methylation. Thienpont and colleagues' findings also raise the question of whether hypoxia could
owards the end of the most recent ice age, northwest America was covered by two immense ice sheets. Where the ice sheets split, there was an ice-free corridor, which was, for decades, considered to be the most probable route for the late-ice-age migration of the first humans into the Americas from Siberia. The corridor was some 1,500 kilometres long, so any path between the ice sheets would have had to develop into a viable habitat to enable humans to journey through it. On page 45, Pedersen et al. 1 report an analysis of ancient DNA, pollen and plant remains in lakesediment samples from British Columbia and Alberta, Canada, at locations corresponding to stretches of the corridor. This research provides the most complete picture yet of the timing and pattern of plant and animal development in a central 'bottleneck' region of the ice-free corridor (thought to be one of the last places in the corridor to become habitable).
It was long thought 2 that human colonizers from Siberia travelled across the exposed Bering land bridge and then through the icefree corridor in western Canada, because it was the only ice-free route to the continental interior. However, subsequent evidence has led to a major re-evaluation 3 . It is now widely accepted that the earliest humans were present in South America by around 14,700 years ago 4, 5 , and that coalescence of the ice sheets blocked the ice-free corridor from 23,000 years ago until at least 15,000-14,000 years ago 6 . Discoveries of the earliest remains in South impair the activity of other dioxygenases that are dependent on Fe 2+ and αKG, including those involved in DNA repair and in the demethylation of DNA-associated histone proteins.
This study also has clinical implications. Many conditions, from heart failure to stroke, can cause lasting oxygen shortage. Is TET activity impaired in these settings in ways that alter gene expression, contributing to disease progression? TET activity is frequently lost in solid tumours, but TET genes are rarely mutated. Could restoring TET activity in hypoxic tumours, for example by increasing levels of vitamin C, αKG or oxygen, reactivate tumour-suppressor genes that have been silenced by hypoxia-induced CpG hypermethylation?
In human tumours, drugs that inhibit bloodvessel formation have only incremental and variable benefits 18 , probably in part because hypoxia contributes to tumour progression and treatment resistance. In some patients, paradoxically, this treatment leads to increased tumour oxygenation and is associated with longer survival. Perhaps making an informed selection of patients on the basis of each individual's TET activity and tumour methylation status could produce therapeutic benefits. Thienpont and colleagues' study reveals a new perspective from which to further investigate the regulation of TET and other dioxygenases that are dependent on Fe 2+ and αKG in the development, and possibly therapeutic intervention, of hypoxia-related diseases. ■
